The instant invention relates to a novel method for the delivery of antitumor drugs to tumor cells by the administration of a tumor-selective antibody- β-lactamase conjugate that binds to tumor cells, and the additional administration of a cephalosporin prodrug that is converted at the tumor site, in the presence of the antibody-β-lactamase, to an active cytotoxic drug. According to the preferred embodiment of this invention, a cephalosporin mustard has been constructed which when cleaved by β-lactamase yields a cytotoxic nitrogen mustard. The methods, antibody-enzyme conjugate, prodrugs, pharmaceutical compositions, and combinations of this invention provide for enhanced selective killing of tumor cells and are thus useful in the treatment of cancers and other tumors.
本发明涉及一种向肿瘤细胞递送
抗肿瘤药物的新方法,该方法是通过给药与肿瘤细胞结合的肿瘤选择性
抗体-β-内酰胺酶共轭物,以及额外给药
头孢菌素原药,在
抗体-β-内酰胺酶存在的情况下,该原药在肿瘤部位转化为活性细胞毒性药物。根据本发明的优选实施方案,已经构建了一种
头孢菌素芥子气,当它被β-内酰胺酶裂解时,会产生一种具有细胞毒性的
氮芥。本发明的方法、
抗体-酶结合物、原药、药物组合物和组合物可增强对肿瘤细胞的选择性杀伤,因此可用于治疗癌症和其他肿瘤。